EUVIMEDEUVIMED entdecken
Open Access

Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia

Jaewoong Lee iD, Ruifeng Sun iD, Kohei Kume iD, Mark E Robinson iD, Zhangliang Cheng, Kadriye Nehir Cosgun iD, Ning Ma iD, Christian Hurtz iD, Huimin Geng iD, Selina M Luger iD, Mark R Litzow iD, Elisabeth Paietta und 3 weitere

Science Signaling · 2026

DOI: 10.1126/scisignal.adw5054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2026. Verfasst von Jaewoong Lee und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center of Molecular and Cellular Oncology, Yale University, New Haven, CT 06511, USA. Hauptthemen laut MEDLINE: Signal Transduction, Interleukin-2 Receptor alpha Subunit, Feedback, Physiological, Protein Kinase C-delta. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD25 is a subunit of the interleukin-2 (IL-2) receptor on T cells and natural killer (NK) cells. Acute leukemias with oncogenic tyrosine kinases often include CD25 + leukemia subpopulations, which portend poor clinical outcomes for patients; however, acute leukemia cells do not respond to IL-2. Here, we identified CD25 and its phosphorylation by protein kinase Cδ (PKCδ) as central elements of a feedback loop that stabilized fluctuations in oncogenic tyrosine kinase signaling in acute lymphoblastic and myeloid leukemia. Genetic ablation of CD25 in murine and patient-derived xenograft (PDX) models of acute leukemias reduced clonal fitness, colony formation, and leukemia-initiation capacity in serial transplant recipients. Oncogenic tyrosine kinase signaling in leukemia cells stimulated NF-κB–mediated CD25 expression, whereas PKCδ-mediated phosphorylation of CD25 suppressed oncogenic tyrosine kinase signaling through inhibitory phosphatases, such as PTPN6. Interactome analyses and mass spectrometry–based global phosphoproteomic analyses showed that CD25 deletion abolished the phosphatase activity of PTPN6, resulting in enhanced activation of tyrosine kinases and NF-κB. Four injections of a CD25 antibody-drug conjugate induced complete remission in mice transplanted with PDX refractory leukemia. These findings highlight the dependency of tyrosine kinase–driven leukemias on robust feedback control and the role of PKCδ and CD25 in assembling its components.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionInterleukin-2 Receptor alpha SubunitFeedback, PhysiologicalProtein Kinase C-deltaLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaAnimalsHumansMicePhosphorylationProtein Tyrosine Phosphatase, Non-Receptor Type 6NF-kappa B

Substanzen

Interleukin-2 Receptor alpha SubunitProtein Kinase C-deltaProtein Tyrosine Phosphatase, Non-Receptor Type 6NF-kappa BIL2RA protein, human

Autor:innen und Institutionen

  • Center of Molecular and Cellular Oncology, Yale University, New Haven, CT 06511, USA.
  • Department of Immunobiology, Yale University, New Haven, CT 06511, USA.
  • School of Biosystems and Biomedical Sciences, College of Health Science, Department of Integrated Biomedical and Life Science, Interdisciplinary Program in Precision Public Health, Korea University, Seoul 02841, South K…
  • Department of Computational and Quantitative Medicine and Department of Systems Biology, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Division of Cancer Sciences, Department of Basic Science, Loma Linda University, Loma Linda, CA 92354, USA.
  • Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.

ORCID-Profile: Jaewoong Lee, Ruifeng Sun, Kohei Kume, Mark E Robinson, Kadriye Nehir Cosgun, Ning Ma, Christian Hurtz, Huimin Geng, Selina M Luger, Mark R Litzow, Jianjun Chen, Nagarajan Vaidehi, Markus Müschen

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • Howard Hughes Medical Institute
  • ASCRS Research Foundation
  • Mark Foundation For Cancer Research
  • National Cancer Institute, Cairo University

Zitieren

APA

Lee, J., Sun, R., Kume, K., Robinson, M. E., Cheng, Z., Cosgun, K. N., Ma, N., Hurtz, C., Geng, H., Luger, S. M., Litzow, M. R., Paietta, E., Chen, J., Vaidehi, N., & Müschen, M. (2026). Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia. Science Signaling. https://doi.org/10.1126/scisignal.adw5054

Vancouver

Lee J, Sun R, Kume K, Robinson ME, Cheng Z, Cosgun KN, et al. Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia. Science Signaling. 2026. doi:10.1126/scisignal.adw5054

BibTeX
@article{Lee2026,
  author = {Lee, Jaewoong and Sun, Ruifeng and Kume, Kohei and Robinson, Mark E and Cheng, Zhangliang and Cosgun, Kadriye Nehir and Ma, Ning and Hurtz, Christian and Geng, Huimin and Luger, Selina M and Litzow, Mark R and Paietta, Elisabeth and Chen, Jianjun and Vaidehi, Nagarajan and Müschen, Markus},
  title = {Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia},
  journal = {Science Signaling},
  year = {2026},
  doi = {10.1126/scisignal.adw5054}
}
Kostenlos starten →